Do you, or somebody close to you, have a decline in memory and thinking skills?
    TRAILBLAZER-ALZ 7 is a clinical research study for people with mild cognitive decline caused by alpha synuclein and amyloid co-pathology. This study is testing an investigational medicine to see if it is safe and may help slow down cognitive decline.
You may be able to join if you meet these criteria:
- Are 55 to 85 years of age
- Â Have gradual cognitive decline, noticed by yourself or somebody close to you
- Have 1 clinical feature of dementia with Lewy-bodies, such as (but not limited to) stiffness, tremor, and/or acting out dreams
- Have markers of amyloid-beta and alpha-synuclein found in blood and CSF that meet the study inclusion
- Have a reliable study partner